Diagnostics Segment PerformanceThe company is executing well and seeing favorable trends in its diagnostics segment and central labs business, which combine for 94% of total revenue.
Earnings PerformanceEarnings exceeded expectations by $0.05, indicating stronger performance than anticipated.
Financial GuidanceFree cash flow guidance was raised by $25 million, suggesting stronger financial health.